216 related articles for article (PubMed ID: 16759642)
1. Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats.
Sato T; Otaka M; Odashima M; Kato S; Jin M; Konishi N; Matsuhashi T; Watanabe S
Biochem Biophys Res Commun; 2006 Jul; 346(1):339-44. PubMed ID: 16759642
[TBL] [Abstract][Full Text] [Related]
2. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
[TBL] [Abstract][Full Text] [Related]
3. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
Itoh T; Tokumura M; Abe K
Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
Makhay MM; Houslay MD; O'Donnell JM
Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide.
Gómez-Cambronero L; Camps B; de La Asunción JG; Cerdá M; Pellín A; Pallardó FV; Calvete J; Sweiry JH; Mann GE; Viña J; Sastre J
J Pharmacol Exp Ther; 2000 May; 293(2):670-6. PubMed ID: 10773043
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S
Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
[TBL] [Abstract][Full Text] [Related]
8. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells.
Yu JH; Kim KH; Kim H
Biochem Pharmacol; 2006 Nov; 72(11):1555-62. PubMed ID: 16934228
[TBL] [Abstract][Full Text] [Related]
9. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
10. Effect of rolipram, a phosphodiesterase IV inhibitor, on allergic footpad swelling using various adjuvants in mice.
Yamaki K; Alam AH; Hossain MA; Taneda S; Yanagisawa R; Takano H; Yoshino S
Scand J Immunol; 2005 Oct; 62(4):378-84. PubMed ID: 16253125
[TBL] [Abstract][Full Text] [Related]
11. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
Thompson BE; Sachs BD; Kantak KM; Cherry JA
Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin attenuates the development of acute pancreatitis in rat.
Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
[TBL] [Abstract][Full Text] [Related]
14. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
Sakura M; Masuda H; Matsuoka Y; Yokoyama M; Kawakami S; Kihara K
BJU Int; 2009 Jan; 103(2):264-9. PubMed ID: 18710439
[TBL] [Abstract][Full Text] [Related]
15. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
Oger S; Behr-Roussel D; Gorny D; Denys P; Lebret T; Alexandre L; Giuliano F
Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
[TBL] [Abstract][Full Text] [Related]
16. Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Yamaki K; Li X; Hossain MA; Alam AH; Taneda S; Yanagisawa R; Takano H; Yoshino S
Immunol Invest; 2007; 36(2):131-45. PubMed ID: 17365015
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin reduces the severity of cerulein-induced acute pancreatitis.
Onur OE; Guneysel O; Akoglu H; Denizbasi A; Onur E
Peptides; 2007 Nov; 28(11):2179-83. PubMed ID: 17928102
[TBL] [Abstract][Full Text] [Related]
18. SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
Griswold DE; Webb EF; Badger AM; Gorycki PD; Levandoski PA; Barnette MA; Grous M; Christensen S; Torphy TJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):705-11. PubMed ID: 9808700
[TBL] [Abstract][Full Text] [Related]
19. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
Harada D; Tsukumo Y; Takashima Y; Manabe H
Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition.
Turner CR; Esser KM; Wheeldon EB
Circ Shock; 1993 Mar; 39(3):237-45. PubMed ID: 8384094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
